Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT04130919

Public ClinicalTrials.gov record NCT04130919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Blinded, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of GS-4875 in Subjects With Moderately to Severely Active Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to demonstrate the efficacy of tilpisertib (formerly GS-4875) compared with placebo control in achieving clinical remission per modified Mayo Clinic Score (MCS) in adults with moderately to severely active ulcerative colitis (UC).

Study identification

NCT ID
NCT04130919
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
19 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2019 (Actual)
Primary completion
Feb 25, 2021 (Actual)
Completion
Dec 14, 2021 (Actual)
Last update posted
Aug 24, 2022

2019 – 2021

United States locations

U.S. sites
23
U.S. states
12
U.S. cities
23
Facility City State ZIP Site status
Gut P.C., dba Digestive Health Specialists of the Southeast Dothan Alabama 36305 —
Om Research LLC Lancaster California 93534 —
United Medical Doctors Murrieta California 92563 —
Alliance Clinical Research Poway California 92064 —
Alliance Medical Research Coral Springs Florida 33071 —
Encore Borland-Groover Clinical Research Jacksonville Florida 32256 —
A Plus Research, Inc Miami Florida 33144 —
BRCR Medical Center Inc. Plantation Florida 33322 —
Advanced Medical Research Center Port Orange Florida 32127 —
Gastrointestinal Specialists of Georgia Marietta Georgia 30060 —
Atlanta Gastroenterology Specialists, PC Suwanee Georgia 30024 —
Louisiana Research Center, LLC Shreveport Louisiana 71105 —
Kansas City Research Institute Kansas City Missouri 64131 —
Advanced Biomedical Research of America Las Vegas Nevada 89123 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
Gastroenterology Associates of Orangeburg Orangeburg South Carolina 29118 —
Vanderbilt University Medical Center - IBD Clinic Nashville Tennessee 37212-1375 —
Allied Digestive Disease Center Cypress Texas 77429 —
Southwest Clinical Trials Houston Texas 77074 —
Clinical Associates in Research Therapeutics of America, LLC San Antonio Texas 78212 —
Texas Digestive Disease Consultants San Marcos Texas 78666 —
Texas Digestive Disease Consultants Southlake Texas 76092 —
Allegiance Research Specialists, LLC Wauwatosa Wisconsin 53225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04130919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2022 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04130919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →